ARCHIVES

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

This article is from The Cancer Letter archive.

Vol. 23 No. 32 | August 15, 1997

Download PDF Visit The Full Archive

Related Articles

New Regimens May Benefit Multiple Myeloma Patients

January 28, 2005

NCI Official Says He Hopes to “Put More Money” Into SPOREs.

April 14, 2006

News Analysis: Filing Will Ignite Complex Litigation Costing Millions, With Uncertain Rewards

March 9, 2012

Fred Conrad, MDA VP, Shot To Death In Hospital Office

January 7, 1983

FDA Approves NDA for Sodium Fluoride F18

February 4, 2011

NTP Staff Members In Bethesda Told They Must Move

December 16, 1983